Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Total assets by reportable segment) (Details)

v3.21.2
Segment Information (Total assets by reportable segment) (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Segment Reporting Information [Line Items]          
Intangible asset, net $ 13,043   $ 13,043   $ 14,629
Tangible assets 394,790   394,790   318,784
Total assets 407,833   407,833   333,413
Sales and marketing expense 9,200 $ 4,600 20,800 $ 12,700  
Dermatology Products Sales [Member]          
Segment Reporting Information [Line Items]          
Intangible asset, net 13,043   13,043   14,629
Tangible assets 67,597   67,597   35,422
Total assets 80,640   80,640   50,051
Pharmaceutical and Biotechnology Product Development [Member]          
Segment Reporting Information [Line Items]          
Intangible asset, net 0   0   0
Tangible assets 327,193   327,193   283,362
Total assets $ 327,193   $ 327,193   $ 283,362